Access cutting-edge diffuse large b-cell lymphoma treatment through this clinical trial at a research site in Olympia. Study-provided care at no cost to qualified participants.
Access diffuse large b-cell lymphoma specialists in Olympia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related diffuse large b-cell lymphoma treatment provided free
The study will measure the safety, tolerability, and efficacy with acalabrutinib in combination with rituximab in treatment-naïve elderly and/or frail patients with diffuse large B-cell lymphoma (DLBCL), who are otherwise unsuitable for standard front line chemoimmunotherapy treatments.
Sponsor: AstraZeneca
Check if you qualify for this diffuse large b-cell lymphoma clinical trial in Olympia, WA
If you're searching for diffuse large b-cell lymphoma treatment options in Olympia, WA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Olympia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diffuse large b-cell lymphoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.